Lepirudin in Treating Patients With Recurrent or Advanced Small Cell Lung Cancer

Stopped early · Phase 1/Phase 2

Conditions studied: Lung Cancer

In brief

RATIONALE: Anticoagulants, such as lepirudin, may help prevent blood clots from forming in patients who have received chemotherapy for small cell lung cancer. PURPOSE: This phase I/II trial is studying the side effects and best dose of lepirudin in treating patients with recurrent or advanced small cell lung cancer.

Key facts

Study ID

NCT00003726

Run by

Dartmouth-Hitchcock Medical Center

People needed

1

Starts

1998-11-01

Expected to finish

2001-07-01

Last updated by the study team

2016-08-08

Who can join

Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Norris Cotton Cancer Center — Lebanon, New Hampshire, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.